Taken together, this study demonstrates that a novel miR-181a/SERPINE1 axis modulates CML stem/progenitor cells, which likely provides an important approach to override TKI resistance. Here, SERPINE1 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.